Crossroads in GDNF therapy for Parkinson
โ
Todd B. Sherer; Brian K. Fiske; Clive N. Svendsen; Anthony E. Lang; J. William L
๐
Article
๐
2006
๐
John Wiley and Sons
๐
English
โ 68 KB
๐ 1 views
## Abstract The development of a neuroprotective or neuroregenerative therapy for Parkinson's disease (PD) would be a major therapeutic advance. Unfortunately, results from a recent controlled clinical study delivering the neurotrophic factor, glialโderived neurotrophic factor (GDNF), directly into